224 related articles for article (PubMed ID: 28154251)
1. Hydroxysafflor Yellow A Alleviates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Mice.
Zhang Y; Song L; Pan R; Gao J; Zang BX; Jin M
Biol Pharm Bull; 2017; 40(2):135-144. PubMed ID: 28154251
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury.
Wu Y; Wang L; Jin M; Zang BX
Biol Pharm Bull; 2012; 35(4):515-22. PubMed ID: 22466555
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS].
Wu W; Jin M; Tong J; Wang XF; Zang BX
Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285
[TBL] [Abstract][Full Text] [Related]
8. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
Sun CY; Pei CQ; Zang BX; Wang L; Jin M
Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures.
Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B
Molecules; 2018 May; 23(5):. PubMed ID: 29783643
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells.
Song L; Zhu Y; Jin M; Zang B
Fitoterapia; 2013 Jan; 84():107-14. PubMed ID: 23160090
[TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
13. [Protective effect of hydroxysafflor yellow A against acute lung injury induced by oleic acid and lipopolysaccharide in rats].
Wang XF; Jin M; Tong J; Wu W; Li JR; Zang BX
Yao Xue Xue Bao; 2010 Jul; 45(7):940-4. PubMed ID: 20931796
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies.
Zhu H; Wang Z; Ma C; Tian J; Fu F; Li C; Guo D; Roeder E; Liu K
Planta Med; 2003 May; 69(5):429-33. PubMed ID: 12802724
[TBL] [Abstract][Full Text] [Related]
15. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow a attenuates small airway remodeling in a rat model of chronic obstructive pulmonary disease.
Wang Y; Xue C; Dong F; Peng Y; Zhang Y; Jin M; Zang B; Tan L
Biol Pharm Bull; 2014; 37(10):1591-8. PubMed ID: 25056232
[TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellow A alleviates myocardial ischemia/reperfusion in hyperlipidemic animals through the suppression of TLR4 signaling.
Han D; Wei J; Zhang R; Ma W; Shen C; Feng Y; Xia N; Xu D; Cai D; Li Y; Fang W
Sci Rep; 2016 Oct; 6():35319. PubMed ID: 27731393
[TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
Jin M; Xue CJ; Wang Y; Dong F; Peng YY; Zhang YD; Zang BX; Tan L
Chin J Integr Med; 2019 Oct; 25(10):750-756. PubMed ID: 30588579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]